March 16, 2020 / 11:33 PM / 17 days ago

BRIEF-Biospecifics Technologies Q4 Revenue $11.8 Million Versus $9.9 Million

March 16 (Reuters) - Biospecifics Technologies Corp :

* BIOSPECIFICS REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL AND OPERATING RESULTS

* Q4 REVENUE $11.8 MILLION VERSUS $9.9 MILLION

* BIOSPECIFICS TECHNOLOGIES - BIOSPECIFICS’ PARTNER, ENDO, EXPECTS THAT XIAFLEX FULL YEAR REVENUE GROWTH WILL BE APPROXIMATELY 20 PERCENT IN 2020 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below